You need to be logged in to view this video
After a three-year bull market and year-and-a-half bear market in biotech stocks, 2017 had seen the return of a stock picker's market within the biotech sector. Join John McCamant as he provides updates on INCY, MDCO, and MDGL,
which were all featured on MoneyShow.com as his Top Picks for 2017. Lastly, he will share his most recent biotech stock recommendations.
which were all featured on MoneyShow.com as his Top Picks for 2017. Lastly, he will share his most recent biotech stock recommendations.
John McCamant
Medical Technology Stock Letter,
Editor
John McCamant joined the leading investment newsletter, Medical Technology Stock Letter, as an associate editor in 1987 and was named editor in August 2000. He has spent over 35 years on the front lines of biotechnology investing. In his previous role as an equities analyst for the American Healthcare fund, Mr. McCamant uncovered investment opportunities and guided investment strategy.
Trending Now
Filter By Category
Filter By Keywords
Loading...